Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. OFIX
stocks logo

OFIX

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
218.69M
+1.41%
-0.220
-70.67%
199.89M
+3.22%
-0.673
-50.12%
213.78M
+5.25%
-0.443
+23.15%
Estimates Revision
The market is revising No Change the revenue expectations for Orthofix Medical Inc. (OFIX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 9.28%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+4.66%
In Past 3 Month
Stock Price
Go Up
up Image
+9.28%
In Past 3 Month
Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is 20.00 USD with a low forecast of 18.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is 20.00 USD with a low forecast of 18.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 15.900
sliders
Low
18.00
Averages
20.00
High
22.00
Current: 15.900
sliders
Low
18.00
Averages
20.00
High
22.00
Barrington
Michael Petusky
Outperform
maintain
$17 -> $18
2025-11-05
Reason
Barrington
Michael Petusky
Price Target
$17 -> $18
2025-11-05
maintain
Outperform
Reason
Barrington analyst Michael Petusky raised the firm's price target on Orthofix to $18 from $17 and keeps an Outperform rating on the shares. The company reported strong Q3 results and upped the low-end of its fiscal 2025 EBITDA outlook, the analyst tells investors in a research note.
Stifel
NULL
to
Buy
initiated
$22
2025-10-28
Reason
Stifel
Price Target
$22
2025-10-28
initiated
NULL
to
Buy
Reason
Stifel resumed coverage of Orthofix with a Buy rating and $22 price target. The firm believes "profitable growth at an attractive valuation" makes it easier to own the shares as investors await long-term ET tailwinds benefiting 7D FLASH, the analyst says while resuming coverage of the spine industry.
Barrington
Michael Petusky
Outperform
maintain
$16 -> $17
2025-08-06
Reason
Barrington
Michael Petusky
Price Target
$16 -> $17
2025-08-06
maintain
Outperform
Reason
Barrington analyst Michael Petusky raised the firm's price target on Orthofix to $17 from $16 and keeps an Outperform rating on the shares. The company reported strong Q2 results and affirmed its fiscal 2025 outlook, the analyst tells investors in a research note.
Barrington
Michael Petusky
Outperform
initiated
$16
2025-06-23
Reason
Barrington
Michael Petusky
Price Target
$16
2025-06-23
initiated
Outperform
Reason
Roth MKM
Jason Wittes
Strong Buy
Reiterates
$22
2025-02-26
Reason
Roth MKM
Jason Wittes
Price Target
$22
2025-02-26
Reiterates
Strong Buy
Reason
Canaccord Genuity
Caitlin Burrows
Strong Buy
Maintains
$24
2025-02-26
Reason
Canaccord Genuity
Caitlin Burrows
Price Target
$24
2025-02-26
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Orthofix Medical Inc (OFIX.O) is -9.41, compared to its 5-year average forward P/E of -11.22. For a more detailed relative valuation and DCF analysis to assess Orthofix Medical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-11.22
Current PE
-9.41
Overvalued PE
91.29
Undervalued PE
-113.74

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
9.97
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.90
Undervalued EV/EBITDA
7.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.99
Current PS
0.00
Overvalued PS
1.41
Undervalued PS
0.57
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

OFIX News & Events

Events Timeline

(ET)
2025-11-04
07:32:20
Orthofix Revises FY25 Revenue Forecast to $810M-$814M, Down from $808M-$816M
select
2025-11-04
07:30:24
Orthofix Announces Q3 Earnings Per Share of 57 Cents, Compared to 71 Cents Last Year
select
2025-08-05 (ET)
2025-08-05
07:46:06
Orthofix backs FY25 revenue view $808M-$816M, consensus $813.4M
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-04NASDAQ.COM
Orthofix Medical Inc. Reports Reduced Losses in Q3

  • Third Quarter Loss: Orthofix Medical Inc. reported a loss of -$22.80 million for the third quarter, an improvement from -$27.39 million in the same period last year.

  • Earnings Per Share: The company's earnings per share (EPS) were -$0.57, compared to -$0.71 in the previous year.

  • Revenue Growth: Revenue increased by 4.6% to $205.63 million, up from $196.61 million year-over-year.

  • Sales Guidance Update: Orthofix has narrowed its fiscal year 2025 net sales guidance to a range of $810 million to $814 million.

[object Object]
Preview
8.0
10-30NASDAQ.COM
Significant Options Activity on Wednesday: DUOL, ORCL, OFIX

  • Oracle Corp Options Trading: Oracle Corp (ORCL) experienced a significant options trading volume of 191,199 contracts, equating to about 19.1 million underlying shares, with a notable focus on the $300 strike call option expiring on October 31, 2025.

  • Orthofix Medical Inc Options Activity: Orthofix Medical Inc (OFIX) saw options trading of 2,000 contracts, representing approximately 200,000 underlying shares, with high activity in the $15 strike put option expiring on November 21, 2025.

  • Comparison of Trading Volumes: The options trading volumes for both ORCL and OFIX reflect a substantial percentage of their average daily trading volumes over the past month, indicating heightened investor interest.

  • Further Information: For additional details on available expirations for DUOL, ORCL, or OFIX options, resources can be found at StockOptionsChannel.com.

[object Object]
Preview
4.0
10-23Benzinga
Barrington Research Reaffirms Outperform Rating for Orthofix Medical, Keeps $17 Price Target Intact

  • Fastest News Alerts: Benzinga Pro offers real-time intelligence to help traders stay updated and make informed decisions in the stock market.

  • Exclusive Stories: The platform provides unique stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing knowledge and strategies.

  • Market Intelligence: Benzinga Pro is positioned as a source for the most accurate and timely stock market intelligence available.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Orthofix Medical Inc (OFIX) stock price today?

The current price of OFIX is 15.9 USD — it has decreased -0.13 % in the last trading day.

arrow icon

What is Orthofix Medical Inc (OFIX)'s business?

Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.

arrow icon

What is the price predicton of OFIX Stock?

Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is 20.00 USD with a low forecast of 18.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Orthofix Medical Inc (OFIX)'s revenue for the last quarter?

Orthofix Medical Inc revenue for the last quarter amounts to 205.63M USD, increased 4.59 % YoY.

arrow icon

What is Orthofix Medical Inc (OFIX)'s earnings per share (EPS) for the last quarter?

Orthofix Medical Inc. EPS for the last quarter amounts to -0.57 USD, decreased -19.72 % YoY.

arrow icon

What changes have occurred in the market's expectations for Orthofix Medical Inc (OFIX)'s fundamentals?

The market is revising No Change the revenue expectations for Orthofix Medical Inc. (OFIX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 9.28%.
arrow icon

How many employees does Orthofix Medical Inc (OFIX). have?

Orthofix Medical Inc (OFIX) has 1616 emplpoyees as of December 05 2025.

arrow icon

What is Orthofix Medical Inc (OFIX) market cap?

Today OFIX has the market capitalization of 629.63M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free